Pharmaceutical Technology BioPharm - May 2025

Pharmaceutical Technology BioPharm - May 2025

Issue link: https://www.e-digitaleditions.com/i/1535562

Contents of this Issue

Navigation

Page 44 of 45

Manufacturing is Changing... Your Cleanroom Strategy Should Too. In today's rapidly evolving pharmaceutical and biotech landscape, flexibility, speed, and compliance are no longer optional — they're essential. G-CON Manufacturing is redefining how cleanrooms are delivered and deployed. Our prefabricated POD ® Cleanrooms are purpose-built to support advanced therapies, personalized medicine, and high-throughput biologics manufacturing — all while meeting the world's strictest regulatory standards. Whether you're scaling cell therapy production, launching a new mAb platform, or establishing a multi-site global network, G-CON POD ® Cleanrooms provide: • Rapid Deployment: Compress timelines from years to months • Scalable Solutions: Expand or reconfigure with minimal disruption • Risk Mitigation: Factory Acceptance Testing (FAT) ensures performance before PODs ever reach your site • Regulatory Confidence: cGMP, ISO 14644-1, and Annex 1–ready designs From R&D through commercial scale, G-CON enables manufacturers to respond to changing science, markets, and technologies — offering reliable cleanroom solutions. Designed for speed. Built for compliance. Scalable for tomorrow. Discover why leading pharmaceutical companies worldwide are choosing G-CON POD ® Cleanrooms. Visit www.gconbio.com, or email us at sales@gconbio.com. Deployed globally with international manufacturing Clients include top 10 pharma companies, with repeat business Forward thinking with optimal designs, including the floorlessPOD and our Hybrid Soluions

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology BioPharm - May 2025 - Pharmaceutical Technology BioPharm - May 2025